GSK-2881078

CAS No. 1539314-06-1

GSK-2881078( GSK2881078 | GSK 2881078 )

Catalog No. M12175 CAS No. 1539314-06-1

A potent and selective androgen receptor modulator (SARM) for the treatment of cachexia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 58 In Stock
10MG 87 In Stock
25MG 192 In Stock
50MG 312 In Stock
100MG 520 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK-2881078
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective androgen receptor modulator (SARM) for the treatment of cachexia.
  • Description
    A potent and selective androgen receptor modulator (SARM) for the treatment of cachexia.Other Indication Phase 1 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GSK2881078 | GSK 2881078
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    AndrogenReceptor
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    1539314-06-1
  • Formula Weight
    330.3254
  • Molecular Formula
    C14H13F3N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 33 mg/mL
  • SMILES
    N#CC1=C(C(F)(F)F)C2=C(N([C@H](C)CS(=O)(C)=O)CC2)C=C1
  • Chemical Name
    1H-Indole-5-carbonitrile, 1-[(1R)-1-methyl-2-(methylsulfonyl)ethyl]-4-(trifluoromethyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BAY 1024767

    BAY 1024767 (BAY1024767) is a higly potent antagonist of androgen receptor (AR) wild-type (IC50=46 nM) and mutant forms located in the AR ligand-binding domain (LBD).

  • Rezvilutamide

    Rezvilutamide (SHR3680) is an orally available androgen receptor inhibitor that crosses the blood-brain barrier and has antitumor activity.Rezvilutamide (SHR3680) is used in the study of metastatic desmoplasia-resistant prostate cancer.

  • LY305

    LY305 (LY-305) is a non-steroidal selective androgen receptor modulator (SARM) with Ki of 2.03 nM.